» Articles » PMID: 2885235

Bioenergetics of Tumor Cells: Glutamine Metabolism in Tumor Cell Mitochondria

Overview
Journal Int J Biochem
Specialty Biochemistry
Date 1987 Jan 1
PMID 2885235
Citations 8
Authors
Affiliations
Soon will be listed here.
Citing Articles

Design and evaluation of novel glutaminase inhibitors.

McDermott L, Iyer P, Vernetti L, Rimer S, Sun J, Boby M Bioorg Med Chem. 2016; 24(8):1819-39.

PMID: 26988803 PMC: 6300166. DOI: 10.1016/j.bmc.2016.03.009.


Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma.

Yu D, Shi X, Meng G, Chen J, Yan C, Jiang Y Oncotarget. 2015; 6(10):7619-31.

PMID: 25844758 PMC: 4480704. DOI: 10.18632/oncotarget.3196.


(13)C-Leucine-tracer-technique for in-vivo measurement of amino acids' metabolism by human colon carcinomas.

Hagmuller E, Gunther H, Saeger H, Kolmar H, Striebel J, Ghoos Y Amino Acids. 2013; 1(2):283-7.

PMID: 24194114 DOI: 10.1007/BF00806927.


Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes.

Colombo S, Palacios-Callender M, Frakich N, Leon J, Schmitt C, Boorn L Proc Natl Acad Sci U S A. 2010; 107(44):18868-73.

PMID: 20921411 PMC: 2973876. DOI: 10.1073/pnas.1012362107.


'Why do tumour cells glycolyse?': from glycolysis through citrate to lipogenesis.

Costello L, Franklin R Mol Cell Biochem. 2006; 280(1-2):1-8.

PMID: 16511951 PMC: 4461431. DOI: 10.1007/s11010-005-8841-8.